|
AP200704090A0
|
|
Novel pharmaceutical composition
|
|
AU2004273892A1
|
|
Method of applying oral compositions
|
|
GB0007760D0
|
|
Composition
|
|
GB0007762D0
|
|
Composition
|
|
GB9824893D0
|
|
Novel method of treatment
|
|
EP1038020A1
|
|
Secreted protein nsl4
|
|
EP0915161A2
|
|
DnaG DNA primase of Streptococcus pneumoniae
|
|
EP0894856A1
|
|
A human sMAD3 splice variant
|
|
EP1009431A1
|
|
Human tumor necrosis factor receptor-like 2 (tr2) antibodies
|
|
EP0877030A2
|
|
EPO primary response gene 1,(EPRG1)
|
|
BR9611520A
|
|
Hemoregulatory compound.
|
|
AP9801315A0
|
|
IL-8 receptor antagonists.
|
|
HU9400027A3
|
|
Alpha-adrenergic receptor antagonists and methods of use thereas
|
|
FI943835A0
|
|
Intermediates which are used for preparing inhibitors for steroid 5-alpha-reductase
|
|
IL105198D0
|
|
Trifluoromethylsulfonate derivatives of estr-tri-and tetra-enes
|
|
PT101061A
|
|
PHARMACEUTICAL COMPOSITIONS CONTAINING ANAGOLS OF CAMPTOTECIN AND A PLATINUM COORDINATION COMPOUND AND ITS USE IN THE INHIBITION OF TUMOR CELL GROWTH
|
|
CZ396991A3
|
|
derivatives of aliphatic acids and pharmaceutical compositions in which they are comprised
|
|
CS397691A3
|
|
Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and theiruse as 5-lipoxygenase pathway inhibitors
|
|
CZ396891A3
|
|
Thiophenylalkane acids, process of their preparation and pharmaceutical preparations in which they are comprised
|
|
FI915918A0
|
|
Fruit procedure for framstaellning av ett 6,7-dihydro- (5h) -pyrrolo (1,2-a) -imidazolderivat och ny mellanprodukt.
|
